Myonecrosis after revascularization procedures

Journal of the American College of Cardiology

Volumn 31, Issue 2, 1998, Pages 241-251

  Califf, Robert M ^a   Abdelmeguid, Alaa E ^b   Kuntz, Richard E ^c   Popma, Jeffrey J ^d   Davidson, Charles J ^e   Cohen, Eric A ^f   Kleiman, Neal S ^g   Mahaffey, Kenneth W ^a   Topol, Eric J ^h   Pepine, Carl J ⁱ   Lipicky, Ray J ^j   Granger, Christopher B ^a   Harrington, Robert A ^a   Tardiff, Barbara E ^a   Crenshaw, Brian S ^a   Bauman, Robert P ^a   Zuckerman, Bram D ^j   Chaitman, Bernard R ^k   Bittl, John A ^l   Ohman, E Magnus ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g HOUSTON METHODIST HOSPITAL   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^j CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^k SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB;

CORONARY ARTERY BYPASS GRAFT; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; MULTIVARIATE ANALYSIS; MUSCLE NECROSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; Q WAVE; REVIEW; RISK FACTOR;

EID: 0031965561     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00506-8     Document Type: Article

References (99)

1. Goldman L. Cost and quality of life thrombolysis and primary angioplasty . J Am Coll Cardiol. 25:(Suppl 7):1995;38S-41S.
2. Dixon SH Jr, Limbird LE, Roe CR, Wagner GS, Oldham HN Jr, Sabiston DC Jr. Recognition of postoperative acute myocardial infarction: application of isoenzyme techniques. Circulation 1973;47/48 Suppl III:III-137-III-140.
3. Rucker CM, Dugall JC, Ganter EL, Kartub MG. The detection of perioperative myocardial infarction in aortocoronary bypass surgery. Chest. 75:1979;300-305.
4. Warren SG, Wagner GS, Bethea CF, Roe CR, Oldham HN, Kong Y. Diagnostic and prognostic significance of electrocardiographic and CPK isoenzyme changes following coronary bypass surgery correlation with findings at one year . Am Heart J. 93:1997;189-196.
5. Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 17:1991;621-626.
6. Kugelmass AD, Cohen DJ, Moscucci M, et al. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 74:1994;748-754.
7. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 59:1979;607-609.
8. Cohen DJ, Krumholz HM, Sukin CA, et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty results from a randomized clinical trial . Circulation. 92:1995;2480-2487.
9. Wagner GS. Optimal use of serum enzyme levels in the diagnosis of acute myocardial infarction. Arch Intern Med. 140:1980;317-319.
10. Dillon MC, Calbreath DF, Dixon AM, et al. Diagnostic problem in acute myocardial infarction CK-MB in the absence of abnormally elevated total creatine kinase levels . Arch Intern Med. 142:1982;33-38.
11. White RD, Grande P, Califf L, Palmeri ST, Califf RM, Wagner GS. Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction. Am J Cardiol. 55:1985;1478-1484.
12. Chu A, Califf RM, Pryor DB, et al. Prognostic effect of bundle branch block related to coronary artery bypass grafting. Am J Cardiol. 59:1987;798-803.
13. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents . Circulation. 90:1994;583-612.
14. Rautaharju PM, Calhoun HP, Chaitman BR. NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. J Electrocardiol. 24:1992;179-187.
15. Crow RS, Prineas RJ, Jacobs DR, Blackburn H. A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changes. Am J Cardiol. 64:1989;454-461.
16. Chaitman BR, Jaffe AS. What is the true periprocedure myocardial infarction rate? Does anyone know for sure? The need for clarification. Circulation. 91:1995;1609-1610.
17. Ambrose JA, Almeida OD, Sharma SK, et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina results of the TAUSA trial . Circulation. 90:1994;69-77.
18. Sutton JM, Ellis SG, Roubin GS, et al., for the Gianturco-Roubin Intracoronary Stent Investigator Group. Major clinical events after coronary stenting: the multicenter registry of acute and elective Gianturco-Roubin stent placement. Circulation 1994;89:1126-37.
19. Bittl JA, Sanborn TA, Tcheng JE, Siegel RM, Ellis SG, for the Percutaneous Excimer Laser Coronary Angioplasty Registry. Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. Am J Cardiol 1992;70:1533-9.
20. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
21. Uusitupa M, Pyorala K, Raunio H, Rissanen V, Lampainen E. Sensitivity and specificity of Minnesota Code Q-QS abnormalities in the diagnosis of myocardial infarction verified at autopsy. Am Heart J. 106:1983;753-757.
22. Hiyoshi Y, Omae T, Hirota Y, Takeshita M, Ueda K, Katsuki S. Clinicopathological study of the heart and coronary arteries of autopsied cases from the community of Hisayama during a 10-year period. Part V. Comparison of autopsy findings with electrocardiograms - Q.QS items of the Minnesota Code. Am J Epidemiol. 121:1985;906-913.
23. Karnegis JN, Matts J, Tuna N. Development and evolution of electrocardiographic Minnesota Q-QS codes in patients with acute myocardial infarction. Am Heart J. 110:1985;452-459.
24. Hindman NB, Schocken DD, Widmann M, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system. Am J Cardiol. 55:1985;1485-1490.
25. Selvester RH, Wagner GS, Hindman NB. The Selvester QRS scoring system for estimating myocardial infarct size the development and application of the system . Arch Intern Med. 145:1985;1877-1881.
26. Roark SF, Ideker RE, Wagner GS, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol. 51:1983;382-389.
27. Ideker RE, Wagner GS, Ruth WK, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol. 49:1982;1604-1614.
28. Ward RM, White RD, Ideker RE, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarcts. Am J Cardiol. 53:1984;706-714.
29. Anderson WD, Wagner NB, Lee KL, et al. Evaluation of a QRS scoring system for estimating myocardial infarct size. VI Identification of screening criteria for non-acute myocardial infarcts . Am J Cardiol. 61:1988;729-733.
30. Sevilla DC, Wagner NB, Pegues R, et al. Sensitivity of a set of myocardial infarction screening criteria in patients with anatomically documented single and multiple infarcts. Am J Cardiol. 66:1990;792-795.
31. Pahlm US, Chaitman BR, Rautaharaju PM, Selvester RH, Wagner GS. Comparison of various electrocardiographic methods for estimating myocardial infarct size [abstract]. Circulation. 94:(Suppl I):1996;I-371.
32. Kent KM, Bentivoglio LG, Block PC, et al. Percutaneous transluminal coronary angioplasty report from the Registry of the National Heart, Lung, and Blood Institute . Am J Cardiol. 49:1982;2011-2020.
33. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 335:1996;217-225.
34. King SB 3rd, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery Emory Angioplasty versus Surgery Trial (EAST) . N Engl J Med. 331:1994;1044-1050.
35. van der Laarse A, Dijkshoorn NJ, Hollaar L, Caspers T. The (iso)enzyme activities of lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase, creatine kinase and aspartate aminotransferase in human myocardial biopsies and autopsies. Clin Chim Acta. 104:1980;381-389.
36. Sylven C, Jansson E, Olin C. Human myocardial and skeletal muscle enzyme activities creatine kinase and its isoenzyme MB as related to citrate synthase and muscle fibre types . Clin Physiol. 3:1983;461-468.
37. Nascimben L, Ingwall JS, Pauletto P, et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation. 94:1996;1894-1901.
38. Ingwall JS, Kramer MF, Fifer MA, et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 313:1985;1050-1054.
39. Scholte HR. On the triple localization of creatine kinase in heart and skeletal muscle of the rat evidence for the existence of myofibrillar and mitochondrial isoenzymes . Biochim Biophys Acta. 305:1973;413-427.
40. Hamman BL, Bittl JA, Jacobus WE, et al. Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. Am J Physiol. 269:1995;H1030-H1036.
41. Ventura-Clapier R, Kuznetov AV, d'Albis A, van Deursen J, Wieringa B, Veksler VI. Muscle creatine kinase deficient mice alterations in myofibrillar function . J Biol Chem. 270:1995;19914-19920.
42. Veksler VI, Kuznetsov AV, Anflous K, et al. Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscle exhibit tissue-specific adaptation of the mitochondrial function. J Biol Chem. 270:1995;19921-19929.
43. McKusick VA. Mendelian Inheritance in Man Catalogs of Autosomal Dominant, Autosomal Recessive and X-linked Phenotypes . 1992;Johns Hopkins University Press, Baltimore.
44. George S, Ishikawa Y, Perryman MB, Roberts R. Purification and characterization of naturally occurring and in vitro induced multiple forms of creatine kinase in plasma. J Biol Chem. 259:1984;2667-2674.
45. Hearse DJ, Humphrey SM. Enzyme release during myocardial anoxia a study of metabolic protection . J Mol Cell Cardiol. 7:1975;463-482.
46. Ahmed SA, Williamson JR, Roberts R, Clark RE, Sobel BE. The association of increased plasma MB CPK activity and irreversible ischemic myocardial injury in dog. Circulation. 54:1976;187-193.
47. Sobel BE, Roberts R, Larson KB. Considerations in the use of biochemical markers of ischemic injury. Circ Res. 38:(Suppl I):1976;I-99-I-108.
48. Cohen L, Morgan J, Gustafson G. Enzyme and isoenzyme analysis in the coronary care unit. Das Gupta DS. Principles and Practice of Acute Cardiac Care. 1984;383-403 Year Book, Chicago.
49. Kjekshus JK, Sobel BE. Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res. 1970;403-414.
50. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest. 50:1971;2614-2625.
51. Conrad GL, Rau EE, Shine KI. Creatine kinase release, potassium-42 content, and mechanical performance in anoxic rabbit myocardium. J Clin Invest. 64:1979;155-161.
52. Bittl JA, Weisfeldt ML, Jacobus WE. Creatine kinase of heart mitochondria the progressive loss of enzyme activity during in vivo ischemia and its correlation to depressed myocardial function . J Biol Chem. 1985:1996;208-214.
53. Neubauer S, Hamman BL, Perry SB, Bittl JA, Ingwall JS. Velocity of the creatine kinase reaction decreases in postischemic myocardium a 31P-NMR magnetization transfer study of the isolated ferret heart . Circ Res. 63:1988;1-15.
54. DeLuca MA, Ingwall JS, Bittl JA. Effects of oxygen and glucose deprivation on myocardial cells in culture. Biochem Biophys Res Commun. 59:1974;749-756.
55. Feng YJ, Chen L, Ma L, et al. Release of troponin I from short-term hibernating myocardium subtended severe coronary stenosis [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;109A.
56. Karim MA, Shinn M, Oskarsson H, Windle J, Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol. 76:1995;521-523.
57. Bittl JA, DeLayre J, Ingwall JS. Rate equation for creatine kinase predicts the in vivo reaction velocity 31-NMR surface coil studies in brain, heart, and skeletal muscle of the living rat . Biochemistry. 26:1987;6083-6090.
58. Lee TH, Weisberg MC, Cook EF, Daley K, Brand DA, Goldman L. Evaluation of creatine kinase and creatine kinase-MB for diagnosing myocardial infarction. Arch Intern Med. 147:1987;115-121.
59. Califf RM, Ohman EM. The diagnosis of acute myocardial infarction. Chest. 101:1992;106S-115S.
60. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 327:1992;146-150.
61. Ohman EM, Califf RM, Topol EJ. Cardiac troponins in acute coronary syndromes. N Engl J Med. 336:1997;1257-1259.
62. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.
63. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury is MB creatine kinase the choice for the 1990s? Circulation. 88:1993;750-763.
64. Ohman EM, Casey C, Bengtson JR, Pryor D, Tormey W, Horgan JH. Early detection of acute myocardial infarction additional diagnostic information by serum myoglobin in patients without ST elevation . Br Heart J. 63:1990;335-338.
65. Jaffe AS, Serota H, Grace A, Sobel BE. Diagnostic changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction. Circulation. 74:1986;105-109.
66. Katus HA, Remppis A, Scheffold T, Diederich KW. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 67:1991;1360-1367.
67. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
68. Hunt AC, Chow SL, Shiu MF, Chilton DC, Cummins B, Cummins P. Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty. Eur Heart J. 12:1991;690-694.
69. Rupprecht HJ, Terres W, Ozbek C, et al. Recombinant hirudin (HBW 023) prevents troponin-T release after coronary angioplasty in patients with unstable angina. J Am Coll Cardiol. 26:1995;1637-1642.
70. Talasz H, Genser N, Mair J, et al. Side-branch occlusion during percutaneous transluminal coronary angioplasty. Lancet. 339:1992;1380-1382.
71. Chaitman BR, Alderman EL, Sheffield LT, et al. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation. 67:1983;302-309.
72. 99mTc-glucoheptonate myocardial imaging and myocardial-specific isoenzymes . Ann Thorac Surg. 27:1979;42-48.
73. McGregor CG, Muir AL, Smith AF, et al. Myocardial infarction related to coronary artery bypass graft surgery. Br Heart J. 51:1984;399-406.
74. Mangano DT, Browner WS, Hollenberg M, Li J, Tateo IM. Long-term cardiac prognosis following noncardiac surgery the Study of Perioperative Ischemia Research Group . JAMA. 268:1992;233-239.
75. Abdelmeguid AE, Whitlow PL, Sapp SK, Ellis SG, Topol EJ. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation. 91:1995;2733-2741.
76. Abdelmeguid AE, Ellis SG, Sapp SK, Whitlow PL, Topol EJ. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J. 131:1996;1097-1105.
77. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 94:1996;1528-1536.
78. Harrington RA, Lincoff AM, Califf RM, et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT) . J Am Coll Cardiol. 25:1995;1693-1699.
79. Elliott JM, Berdan LG, Holmes DR, et al. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I). Circulation. 91:1995;2158-2166.
80. 3 blockade with percutaneous coronary intervention. JAMA. 278:1997;479-484.
81. Redwood SR, Popma JJ, Kent KM, et al. "Minor" CPK-MB elevations are associated with increased late mortality following ablative new-device angioplasty in native coronary arteries [abstract]. Circulation. 92:(Suppl I):1995;I-544.
82. Tardiff BE, Califf RM, Tcheng JE, et al. Post-intervention cardiac enzyme elevations prognostic significance in IMPACT II [abstract] . J Am Coll Cardiol. 27:(Suppl A):1996;83A.
83. Tardiff BE, Mahaffey KW, Sigmon KN, et al. Prognostic significance of cardiac enzyme elevations detected through systematic screening in clinical trials [abstract]. Control Clin Trials. 17:1996;135S.
84. Kong TQJ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA. 277:1997;461-466.
85. Ohman EM, Tardiff BE. Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization importance and implications . JAMA. 277:1997;495-497.
86. Baim DS, Popma JJ, Sharma SK, et al. Final results in the Balloon vs Optimal Atherectomy Trial (BOAT) 6 month angiography and 1 year clinical follow-up [abstract] . Circulation. 94:(Suppl I):1996;I-436.
87. Cutlip DE, Baim DS, Senerchia C, et al. Clinical consequences of myocardial infarction following balloon angioplasty or directional coronary atherectomy acute and one year results of the Balloon vs. Optimal Atherectomy Trial (BOAT) [abstract] . J Am Coll Cardiol. 29:(Suppl A):1997;187A-188A.
88. Mager A, Sclarovsky S, Wurtzel M, Menkes H, Strasberg B, Rechavia E. Ischemia and reperfusion during intermittent coronary occlusion in man studies of electrocardiographic changes and CPK release . Chest. 99:1991;386-392.
89. Muhlestein JB, Quigley PJ, Ohman EM, et al. Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans. J Am Coll Cardiol. 20:1992;594-598.
90. Spadaro JJ, Ludbrook PA, Tiefenbrunn AJ, Kurnik PB, Jaffe AS. Paucity of subtle myocardial injury after angioplasty delineated with MB CK. Cathet Cardiovasc Diagn. 12:1986;230-234.
91. Oh JK, Shub C, Ilstrup DM, Reeder GS. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 109:1985;1225-1231.
92. Pauletto P, Piccolo D, Scannapieco G, et al. Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris. Am J Cardiol. 59:1987;999-1000.
93. Liu MW, Douglas JS Jr, Lembo NJ, King SB III. Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts. Am J Cardiol. 72:1993;514-517.
94. Narins CR, Hillegass WB Jr, Nelson CL, et al. Relation between activated clotting time during angioplasty and abrupt closure. Circulation. 93:1996;667-671.
95. Gurbel PA, Navetta FI, Bates ER, et al. Lesion-directed administration of tissue-plasminogen activator with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Cathet Cardiovasc Diagn. 36:1995;377-380.
96. Van de Werf F. More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa blockade during coronary interventions - latest results from the EPILOG and CAPTURE trials. Eur Heart J. 17:1996;325-326.
97. Fishbein MC, Y-Rit J, Lando U, Kanmatsuse K, Mercier JC, Ganz W. The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation. 62:1980;1274-1279.
98. Redwood SR, Popma JJ, Kent KM, et al. Predictors of late mortality following ablative new-device angioplasty in native coronary arteries [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;167A-168A.
99. Kong TQ, Meyers SN, Parker MA, Elliott MD, Davidson CJ. Predictors and late sequelae of distal embolization in patients with creatine kinase elevation following elective PTCA [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;360A.